Insider Selling: Bruce G. Anderson Sells 10,000 Shares of CryoLife Stock (CRY)
CryoLife (NYSE:CRY) VP Bruce G. Anderson unloaded 10,000 shares of the company’s stock on the open market in a transaction dated Monday, August 18th. The stock was sold at an average price of $10.52, for a total value of $105,200.00. Following the completion of the sale, the vice president now directly owns 34,564 shares in the company, valued at approximately $363,613. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of CryoLife (NYSE:CRY) traded down 1.04% during mid-day trading on Tuesday, hitting $10.49. The stock had a trading volume of 63,512 shares. CryoLife has a 1-year low of $6.01 and a 1-year high of $12.14. The stock’s 50-day moving average is $9.59 and its 200-day moving average is $9.49. The company has a market cap of $292.9 million and a price-to-earnings ratio of 19.78.
CryoLife (NYSE:CRY) last posted its quarterly earnings results on Thursday, July 24th. The company reported $0.08 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.05 by $0.03. The company had revenue of $34.69 million for the quarter, compared to the consensus estimate of $35.72 million. During the same quarter last year, the company posted $0.08 earnings per share. CryoLife’s revenue was up 3.6% compared to the same quarter last year. Analysts expect that CryoLife will post $0.20 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, September 19th. Shareholders of record on Friday, September 12th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 1.14%. The ex-dividend date is Wednesday, September 10th.
CryoLife, Inc (NYSE:CRY) is a biological medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.